<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="Correlation of Findings in Advanced MRI Techniques with Global Severity Scales in Patients with Parkinson Disease" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/correlation-of-findings-in-advanced-mri-techniques-with-global-severity-scales-in-patients-with-park/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/correlation-of-findings-in-advanced-mri-techniques-with-global-severity-scales-in-patients-with-park/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2011-01-31T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="Correlation of Findings in Advanced MRI Techniques with Global Severity Scales in Patients with Parkinson Disease" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-07T07:15:32+00:00","datePublished":"2011-01-31T17:00:00+00:00","description":"Rationale and Objectives","headline":"Correlation of Findings in Advanced MRI Techniques with Global Severity Scales in Patients with Parkinson Disease","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/correlation-of-findings-in-advanced-mri-techniques-with-global-severity-scales-in-patients-with-park/"},"url":"https://clinicaltree.github.io/posts/correlation-of-findings-in-advanced-mri-techniques-with-global-severity-scales-in-patients-with-park/"}</script><title>Correlation of Findings in Advanced MRI Techniques with Global Severity Scales in Patients with Parkinson Disease | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>Correlation of Findings in Advanced MRI Techniques with Global Severity Scales in Patients with Parkinson Disease</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>Correlation of Findings in Advanced MRI Techniques with Global Severity Scales in Patients with Parkinson Disease</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1296493200" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Jan 31, 2011 </em> </span> <span> Updated <em class="" data-ts="1680851732" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 7, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Pedro J. Modrego MD</a> </em>, <em> <a href="">Nicolás Fayed MD</a> </em>, <em> <a href="">Jorge Artal MD</a> </em>, <em> <a href="">Salvador Olmos PhD</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="2088 words"> <em>11 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>This work is aimed at determining whether magnetic resonance spectroscopy (MRS) and diffusion tensor imaging (DTI) may correlate with disease severity in a series of Parkinson disease (PD) patients.</p><h2 id="materials-and-methods"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>We recruited a consecutive sample of 39 PD patients in several stages of the disease according to Hoehn and Yahr scale. There were 22 men, and the mean age was 74.5 years (SD 7.5). Disease severity was measured with the Unified Parkinson Disease Rating Scale (UPDRS). All of them underwent 1 H MRS in basal ganglia and the anterior cingulate area, as well as DTI in bilateral substantia nigra. Correlation was made between radiological findings and UPDRS.</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>We found significant negative correlation between UPDRS scores and the Glx (glutamate+glutamine) levels in the right ( <em>r</em> = −0.35; <em>P</em> = .03) and the left ( <em>r</em> = −0.44; <em>P</em> = .006) lentiform nucleus; as well as with glutamate ( <em>r</em> = −0.43; <em>P</em> = .008), the Glx/Cr ratio in the right ( <em>r</em> = −0.41; <em>P</em> = .01), and in the left lentiform nucleus ( <em>r</em> = −0.36; <em>P</em> = .02). We also found positive correlation between UPDRS scores and DTI in right rostral substantia nigra ( <em>r</em> = 0.36; <em>P</em> = .02). Glx was increased in lentiform nucleus and fractional anisotropy was reduced in the rostral SN of subjects with PD in early stages.</p><h2 id="conclusions"><span class="mr-2">Conclusions</span><a href="#conclusions" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>The results are consistent with the view that more than half the dopaminergic neurons in the nigrostriatal projection are lost before the onset of PD.</p><p>Parkinson disease (PD) is a frequent disease in the elderly. To date and with exception of positron emission tomography there is no specific radiological marker of the disease. However a marker should be useful to monitor progression and response to treatment.</p><p>Magnetic resonance spectroscopy (MRS) provides a noninvasive method for characterizing chemical and cellular features in vivo. MRS can be used to measure the chemical composition of tissues, characterize certain tissue metabolic processes, and identify unanticipated chemical or metabolic relationships with disease. In brain tissue, the concentrations and mobility of MRS-visible, low-molecular-weight chemicals are measured as spectral peaks and can be used to detect abnormalities in brain regions that seem normal in magnetic resonance imaging (MRI) and to elucidate the pathology underlying MRI-visible abnormalities .</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="patients-and-methods"><span class="mr-2">Patients and methods</span><a href="#patients-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><ul><li><p>1. <a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><li><p>2. <a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><li><p>3. <a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><li><p>4. <a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p></ul><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><ul><li><p>a) <a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><li><p>b) <a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p></ul><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CorrelationofFindingsinAdvancedMRITechniqueswithGlobalSeverityScalesinPatientswithParkinsonDisease/0_1s20S107663321000574X.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CorrelationofFindingsinAdvancedMRITechniqueswithGlobalSeverityScalesinPatientswithParkinsonDisease/0_1s20S107663321000574X.jpg" alt="Figure 1, Voxel placement in the lentiform nuclei with echoplanar axial sequences (a, b) , and in the anterior cingulate area with sagittal T1-weighted MRI (c) ." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><ul><li>c) <a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></ul><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CorrelationofFindingsinAdvancedMRITechniqueswithGlobalSeverityScalesinPatientswithParkinsonDisease/1_1s20S107663321000574X.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CorrelationofFindingsinAdvancedMRITechniqueswithGlobalSeverityScalesinPatientswithParkinsonDisease/1_1s20S107663321000574X.jpg" alt="Figure 2, Example of a spectrum acquired with the LCModel software showing an increased peak of Glx (glutamate+glutamine)." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CorrelationofFindingsinAdvancedMRITechniqueswithGlobalSeverityScalesinPatientswithParkinsonDisease/2_1s20S107663321000574X.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CorrelationofFindingsinAdvancedMRITechniqueswithGlobalSeverityScalesinPatientswithParkinsonDisease/2_1s20S107663321000574X.jpg" alt="Figure 3, Axial echoplanar sequences depicting the substantia nigra and red nucleus (a) , substance nigra (b) ; regions of interest (ROIs) in rostral, medial, and caudal substantia nigra (SN); ROI in the cerebral peduncle (c) ." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="ethical-aspects"><span class="mr-2">Ethical Aspects</span><a href="#ethical-aspects" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-1"><span class="mr-2">Results</span><a href="#results-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CorrelationofFindingsinAdvancedMRITechniqueswithGlobalSeverityScalesinPatientswithParkinsonDisease/3_1s20S107663321000574X.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CorrelationofFindingsinAdvancedMRITechniqueswithGlobalSeverityScalesinPatientswithParkinsonDisease/3_1s20S107663321000574X.jpg" alt="Figure 4, Fractional anisotropy in the right rostral substantia nigra, and Unified Parkinson Disease Rating Scale (UPDRS) scores." class="lazyload" data-proofer-ignore></a></p><p>Table 1</p><p>Values of Fractional Anisotropy</p><p>Explored ROI Means and SD (Left) Means and SD (Right) Rostral SN 0.259 (0.05) 0.242 (0.04) Medial SN 0.339 (0.055) 0.345 (0.07) Caudal SN 0.239 (0.058) 0.276 (0.05) Cerebral peduncle 0.344 (0.06) 0.382 (0.06)</p><p>ROI, region of interest; SD, standard deviation; SN, substantia nigra.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 2</p><p>Metabolite Values (ppm) and Ratios to Creatine by Every Area of Exploration</p><p>Metabolite Anterior Cingulate Area Right Lentiform Nucleus Left Lentiform Nucleus Creatine 5.25 (1.3) 5.52 (0.6) 5.28 (0.68) Glutamate 7.22 (2.1) 6.98 (0.99) 7.29 (1.01) Glutamate/Cr 1.37 (0.38) 1.27 (0.18) 1.4 (0.2) mI 5.15 (1.86) 4.39 (0.83) 4.08 (0.81) mI/Cr 0.99 (0.28) 0.80 (0.12) 0.78 (0.13) NAA 5.15 (1.27) 5.23 (0.92) 5.43 (0.96) NAA/Cr 0.99 (0.23) 0.95 (0.17) 1.03 (0.17) Choline 1.45 (0.41) 1.51 (0.17) 1.4 (0.2) Choline/Cr 0.27 (0.48) 0.27 (0.24) 0.27 (0.31) Glx 11.06 (3.51) 11.32 (1.2) 10.98 (1.47) Glx/Cr 2.13 (0.64) 2.05 (0.27) 2.1 (0.34)</p><p>Cr, total creatine; Glx, glutamate+glutamine; mI, myo-inositol; NAA, N-acetyl-aspartate.</p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CorrelationofFindingsinAdvancedMRITechniqueswithGlobalSeverityScalesinPatientswithParkinsonDisease/4_1s20S107663321000574X.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CorrelationofFindingsinAdvancedMRITechniqueswithGlobalSeverityScalesinPatientswithParkinsonDisease/4_1s20S107663321000574X.jpg" alt="Figure 5, Glx in the left lentiform nucleus and Unified Parkinson Disease Rating Scale (UPDRS) scores." class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CorrelationofFindingsinAdvancedMRITechniqueswithGlobalSeverityScalesinPatientswithParkinsonDisease/5_1s20S107663321000574X.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CorrelationofFindingsinAdvancedMRITechniqueswithGlobalSeverityScalesinPatientswithParkinsonDisease/5_1s20S107663321000574X.jpg" alt="Figure 6, Ratios of Glx/Cr in the right lentiform and Unified Parkinson Disease Rating Scale (UPDRS) scores." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="correlations-between-brain-metabolites-and-variables"><span class="mr-2">Correlations between Brain Metabolites and Variables</span><a href="#correlations-between-brain-metabolites-and-variables" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Fayed N., Olmos S., Morales H., et. al.: Physical basis of magnetic resonance spectroscopy and its application to central nervous system diseases. Am J Appl Sci 2006; 3: pp. 1836-1845.</p><li><p>2. Holshouser B.A., Komu M., Moller H.E., et. al.: Localized proton NMR spectroscopy in the striatum of patients with idiopathic Parkinson’s disease: a multicenter pilot study. Magn Reson Med 1995; 33: pp. 589-594.</p><li><p>3. Camicioli R.M., Hanstock C.C., Bouchard T.P., et. al.: Magnetic resonance spectroscopic evidence for presupplementary motor area neuronal dysfunction in Parkinson’s disease. Mov Disord 2007; 22: pp. 382-386.</p><li><p>4. Firbank M.J., Harrison R.M., O’Brian J.T.: A comprehensive review of proton magnetic resonance spectroscopy studies in dementia and Parkinson’s disease. Dement Geriatr Cogn Disord 2002; 14: pp. 64-76.</p><li><p>5. Taylor-Robinson S.D., Turjanski N., Bhattacharya S., et. al.: A proton magnetic resonance spectroscopy study of the striatum and cerebral cortex in Parkinson’s disease. Metab Brain Dis 1999; 14: pp. 45-55.</p><li><p>6. Davie C.A., Wenning G.K., Barker G.J., et. al.: Differentiation of multiple system atrophy from idiopathic Parkinson’s disease using proton magnetic resonance spectroscopy. Ann Neurol 1995; 37: pp. 204-210.</p><li><p>7. Tedeschi G., Litvan I., Bonavita S., et. al.: Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson’s disease and corticobasal degeneration. Brain 1997; 120: pp. 1541-1552.</p><li><p>8. O’Neil J., Schuff N., Marks W.J., et. al.: Quantitative 1H magnetic resonance spectroscopy and MRI of Parkinson’s disease. Movement Disord 2002; 17: pp. 917-927.</p><li><p>9. Summerfield C., Gómez-Ansón B., Tolosa E., et. al.: Dementia in Parkinson disease: a proton magnetic resonance spectroscopy study. Neurol Arch 2002; 59: pp. 1415-1420.</p><li><p>10. Jones D.K., Williams S.C., Gasston D., et. al.: Isotropic resolution diffusion tensor imaging with whole brain acquisition in a clinically acceptable time. Hum Brain Mapp 2002; 15: pp. 216-230.</p><li><p>11. Karagulle Kendi A.T., Lehericy S., Luciana M., et. al.: Altered diffusion in the frontal lobe in Parkinson disease. AJNR Am J Neuroradiol 2008; 29: pp. 501-505.</p><li><p>12. Chan L.L., Rumpel H., Yap K., et. al.: Case control study of diffusion tensor imaging in Parkinson’s disease. J Neurol Neurosurg Psychiatry 2007; 78: pp. 1383-1386.</p><li><p>13. Boska M.D., Hasan K.M., Kibuule D., et. al.: Quantitative diffusion tensor imaging detects dopaminergic neuronal degeneration in a murine model of Parkinson’s disease. Neurobiol Dis 2007; 26: pp. 590-596.</p><li><p>14. Fearnley J.M., Lees A.J.: Ageing and Parkinson’s disease: substantia nigra regional selectivity. Brain 1991; 114: pp. 2283-2301.</p><li><p>15. Martin W.R., Wieler M., Gee M.: Midbrain iron content in early Parkinson disease: a potential biomarker of disease status. Neurology 2008; 70: pp. 1411-1417.</p><li><p>16. Gelb D.J., Oliver E., Gilman S.: Diagnostic criteria for Parkinson’s disease. Arch Neurol 1999; 56: pp. 33-39.</p><li><p>17. Provencher S.W.: Estimation of metabolite concentrations from localised in vivo proton NMR spectra. Magn Reson Med 1993; 30: pp. 672-679.</p><li><p>18. Fayed N., Modrego P.J., Medrano J.: Comparative test-retest reliability of metabolite values assessed with magnetic resonance spectroscopy of the brain. The LCModel versus the manufacturer software. Neurol Res 2009; 31: pp. 472-477.</p><li><p>19. Basser P.J., Pierpaoli C.: Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J Magn Reson B 1996; 111: pp. 209-219.</p><li><p>20. Oikawa H., Sasaki M., Tamakawa Y., et. al.: The substantia nigra in Parkinson disease: proton density weighted spin-echo and fast short inversion time inversion recovery MR findings. AJNR Am J Neuroradiol 2002; 23: pp. 1747-1756.</p><li><p>21. Vaillancourt D.E., Spraker M.B., Prodoehl J., et. al.: High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Neurology 2009; 72: pp. 1378-1384.</p><li><p>22. Abe O., Aoki S., Hayashi N., et. al.: Normal aging in the central nervous system: quantitative MR diffusion-tensor analysis. Neurobiol Aging 2002; 23: pp. 433-441.</p><li><p>23. Tievsky A.L., Ptak T., Farkas J.: Investigation of apparent diffusion coefficient and diffusion tensor anisotropy in acute and chronic multiple sclerosis lesions. Am J Neuroradiol 1999; 20: pp. 1491-1499.</p><li><p>24. Yoshikawa K., Nakata Y., Yamada K., et. al.: Early pathological changes in the parkinsonian brain demonstrated by diffusion tensor MRI. J Neurol Neurosurg Psychiatry 2004; 75: pp. 481-484.</p><li><p>25. Griffith H.R., Okonkwo O.C., O’Brien T., et. al.: Reduced brain glutamate in patients with Parkinson’s disease. NMR Biomed 2008; 21: pp. 381-387.</p><li><p>26. Oz G., Terpstra M., Tkác I., et. al.: Proton MRS of the unilateral substantia nigra in the human brain at 4 tesla: detection of high GABA concentrations. Magn Reson Med 2006; 55: pp. 296-301.</p><li><p>27. Kickler N., Krack P., Fraix V., et. al.: Glutamate measurement in Parkinson’s disease using MRS at 3 T field strength. NMR Biomed 2007; 20: pp. 757-762.</p><li><p>28. Taylor-Robinson S.D., Turjanski N., Bhattacharya S., et. al.: A proton magnetic resonance spectroscopy study of the striatum and cerebral cortex in Parkinson’s disease. Metab Brain Dis 1999; 14: pp. 45-55.</p><li><p>29. Clarke C.E., Lowry M., Horsman A.: Unchanged basal ganglia N-acetylaspartate and glutamate in idiopathic Parkinson’s disease measured by proton magnetic resonance spectroscopy. Mov Disord 1997; 12: pp. 297-301.</p><li><p>30. Clarke C.E., Lowry M.: Basal ganglia metabolite concentrations in idiopathic Parkinson’s disease and multiple system atrophy measured by proton magnetic resonance spectroscopy. Eur J Neurol 2000; 7: pp. 661-665.</p><li><p>31. Gruetter R., Weisdorf S.A., Rajanayagan V., et. al.: Resolution improvements in in vivo 1H NMR spectra with increased magnetic field strength. J Magn Reson 1998; 135: pp. 260-264.</p><li><p>32. Di Costanzo A., Trojsi F., Tosetti M., et. al.: High-field proton MRS of human brain. Eur J Radiol 2003; 48: pp. 146-153.</p><li><p>33. Kickler N., Krack P., Fraix V., et. al.: Glutamate measurement in Parkinson’s disease using MRS at 3 T field strength. NMR Biomed 2007; 20: pp. 757-762.</p><li><p>34. Schubert F., Gallinat J., Seifert F., et. al.: Glutamate concentrations in human brain using single voxel proton magnetic resonance spectroscopy at 3 Tesla. Neuroimage 2004; 21: pp. 1762-1771.</p><li><p>35. Coyle J.T., Bird S.J., Evans R.H., et. al.: Excitatory amino acid neurotoxins: selectively and mechanisms of action. Neurosci Res Prog 1981; 19: pp. 331-427.</p><li><p>36. Bosman D.K., Deutz N.E., De Graaf A.A., et. al.: Changes in brain metabolism during hyperammonemia and acute liver failure: Results of a comparative 1H NMR spectroscopy and biochemical investigation. Hepatology 1990; 12: pp. 281-290.</p><li><p>37. Häussinger D., Kircheis G., Fischer R., et. al.: Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema?. J Hepatol 2000; 32: pp. 1035-1038.</p><li><p>38. Duchesne S., Rolland Y., Vérin M.: Automated computer differential classification in parkinsonian syndromes via pattern analysis on MRI. Acad Radiol 2009; 16: pp. 61-70.</p><li><p>39. Raff U., Hutchinson M., Rojas G.M., et. al.: Inversion recovery MRI in idiopathic Parkinson disease is a very sensitive tool to assess neurodegeneration in the substantia nigra: preliminary investigation. Acad Radiol 2006; 13: pp. 721-727.</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-18/'>Volume 18</a>, <a href='/categories/issue-2/'>Issue 2</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=Correlation%20of%20Findings%20in%20Advanced%20MRI%20Techniques%20with%20Global%20Severity%20Scales%20in%20Patients%20with%20Parkinson%20Disease%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fcorrelation-of-findings-in-advanced-mri-techniques-with-global-severity-scales-in-patients-with-park%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=Correlation%20of%20Findings%20in%20Advanced%20MRI%20Techniques%20with%20Global%20Severity%20Scales%20in%20Patients%20with%20Parkinson%20Disease%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fcorrelation-of-findings-in-advanced-mri-techniques-with-global-severity-scales-in-patients-with-park%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fcorrelation-of-findings-in-advanced-mri-techniques-with-global-severity-scales-in-patients-with-park%2F&text=Correlation%20of%20Findings%20in%20Advanced%20MRI%20Techniques%20with%20Global%20Severity%20Scales%20in%20Patients%20with%20Parkinson%20Disease%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/a-preliminary-evaluation-of-multi-probe-resonance-frequency-electrical-impedance-based-measurements/"><div class="card-body"> <em class="small" data-ts="1296493200" data-df="ll" > Jan 31, 2011 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>A Preliminary Evaluation of Multi-probe Resonance-frequency Electrical Impedance Based Measurements of the Breast</h3><div class="text-muted small"><p> Rationale and Objectives The aim of this study was to preliminarily assess the performance of a new, resonance-frequency electrical impedance spectroscopy (REIS) system in identifying young women ...</p></div></div></a></div><div class="card"> <a href="/posts/an-ultrasound-model-to-discriminate-the-risk-of-thyroid-carcinoma/"><div class="card-body"> <em class="small" data-ts="1296493200" data-df="ll" > Jan 31, 2011 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>An Ultrasound Model to Discriminate the Risk of Thyroid Carcinoma</h3><div class="text-muted small"><p> Rationale and Objectives Thyroid nodules are common on ultrasonographic examination and are mostly benign. Ultrasound characteristics may help discriminate thyroid carcinoma (TC) from benign nodul...</p></div></div></a></div><div class="card"> <a href="/posts/comparison-of-chest-dual-energy-subtraction-digital-tomosynthesis-imaging-and-dual-energy-subtractio/"><div class="card-body"> <em class="small" data-ts="1296493200" data-df="ll" > Jan 31, 2011 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Comparison of Chest Dual-energy Subtraction Digital Tomosynthesis Imaging and Dual-energy Subtraction Radiography to Detect Simulated Pulmonary Nodules with and without Calcifications</h3><div class="text-muted small"><p> Rationale and Objectives To compare the effectiveness of chest dual-energy subtraction digital tomosynthesis (DES-DT) imaging with that of DES radiography for detecting simulated pulmonary nodules...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/comparison-of-chest-dual-energy-subtraction-digital-tomosynthesis-imaging-and-dual-energy-subtractio/" class="btn btn-outline-primary" prompt="Older"><p>Comparison of Chest Dual-energy Subtraction Digital Tomosynthesis Imaging and Dual-energy Subtraction Radiography to Detect Simulated Pulmonary Nodules with and without Calcifications</p></a> <a href="/posts/effect-of-intravenous-extracellular-gadolinium-based-contrast-medium-on-renal-diffusion-weighted-ima/" class="btn btn-outline-primary" prompt="Newer"><p>Effect of Intravenous Extracellular Gadolinium Based Contrast Medium on Renal Diffusion Weighted Images</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
